{"product_name":"Ethos","company_name":"Varian","product_url":"https://www.varian.com/products/adaptive-therapy/ethos","company_url":"https://www.varian.com","related_urls":["https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"],"product_code":"SW0223","summary":"Ethos is an AI-driven adaptive radiotherapy system by Varian, designed to personalize cancer treatment by adjusting therapies in real-time based on patient anatomy and tumor changes.","description":"Ethos integrates artificial intelligence with adaptive therapy to optimize radiotherapy planning and delivery. It offers personalized treatment options, efficient workflows, and flexibility in treatment techniques, including adaptive radiotherapy, image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), volumetric-modulated arc therapy (VMAT), and stereotactic body radiotherapy (SBRT). The system leverages diagnostic MR, PET, and CT images during planning and treatment, and features HyperSight imaging for high-resolution, rapid imaging. Enhanced algorithms in the Ethos Intelligent Optimization Engine (IOE) provide optimized treatment planning and dose delivery, while AI-driven segmentation reduces manual contouring. Integration with ARIA CORE oncology management solution facilitates seamless data sharing and patient management. HyperSight imaging, an optional feature, enables direct dose calculation on cone-beam CT images, enhancing treatment adaptation. Ethos received FDA 510(k) clearance in February 2020 and has been updated to version 2.0 with additional functionalities, including expanded AI-segmented anatomical structures and improved connectivity. The system is marketed globally, with Varian's offices in multiple countries, and supports multiple languages. Pricing details are not publicly disclosed; interested parties are advised to contact Varian directly for information. Ethos operates under Varian's proprietary license terms. Varian was founded in 1948 and is headquartered in Palo Alto, California.","categories":["clinical Care","diagnostic Support","patient Facing","clinical Decision Support","radiation Therapy","imaging Software","oncology Care","medical Device","ai Clinical Documentation Integrity","clinical Decision Support","Clinical","Diagnostic","Patient-facing","Treatment Planning","Radiotherapy","Adaptive Therapy","Imaging","Oncology Management","Medical Devices","Artificial Intelligence"],"market_segment":["Enterprise","SMB"],"target_users":["Clinicians","Medical Physicists","Radiation Oncologists","Healthcare Administrators","Patients"],"specialties":["Oncology","Radiation Oncology","Medical Physics","Cancer Treatment","Adaptive Radiotherapy","Imaging","Medical Devices","Artificial Intelligence","Healthcare It","Medical Equipment"],"regions_available":["United States","Canada","European Union","United Kingdom","Australia","Japan","South Korea","China","India","Brazil","Mexico","South Africa","Russia","Middle East","Southeast Asia","Latin America","Africa","New Zealand","Caribbean","Central America"],"languages_supported":["English","Spanish","French","German","Italian","Portuguese","Dutch","Russian","Chinese","Japanese","Korean","Arabic","Hindi","Bengali","Punjabi","Telugu","Marathi","Tamil","Urdu","Gujarati"],"pricing_model":"Enterprise_quote","pricing_details":"Contact vendor for pricing information.","license":"Proprietary","company_offices":["United States","Canada","United Kingdom","Germany","France","Italy","Spain","Netherlands","China","India"],"company_founding":"1948","deployment_model":["on_prem","hybrid"],"os_platforms":["Windows","Linux"],"features":["Adaptive radiotherapy","AI-driven treatment planning","AI-based segmentation","HyperSight imaging integration","ARIA Coexistence","Treatment planning flexibility (adaptive, IGRT, IMRT, VMAT, SBRT)","Integration with diagnostic MR, PET, and CT images","Unified reporting and management of IGRT treatments","Direct dose calculation on HyperSight CBCT images"],"optional_modules":["HyperSight imaging"],"integrations":["ARIA oncology management solution","Varian linear accelerators"],"data_standards":["DICOM","HL7","FHIR"],"api_available":"unknown","system_requirements":"Windows Server 2016 or later, Linux-based servers","compliance":["HIPAA","ISO 27001","SOC 2 Type II","FDA 510(k) clearance"],"certifications":["FDA 510(k) clearance","ISO 27001","SOC 2 Type II"],"security_features":["End-to-end encryption","Role-based access control","Audit trails","Secure data storage"],"privacy_features":["Data anonymization","Data minimization","User consent management"],"data_residency":"US and EU regions","customers":[],"user_reviews":[],"ratings":[],"support_channels":[],"training_options":[],"release_year":"","integration_partners":[],"id":"SW0223","slug":"ethos","type":"product","version":"1.0","last_updated":"2025-10-11","links_json":{"self":"https://www.healthaidb.com/software/ethos.json"}}